Trending Now
Why HempAmericana Inc (OTCMKTS:HMPQ) Deserves Fresh Attention
As we comb through the rubble of the hemp, cannabis, and CBD space, we are starting to find a number of stories that appear...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Humanigen Inc. (NASDAQ:HGEN) Announce Encouraging Phase 3 Lenzilumab Study Results...
Humanigen Inc. (NASDAQ:HGEN) has announced encouraging topline results from its third phase clinical study evaluating the safety and efficacy of lenzilumab in treating hospitalized...
MAKE IT MODERN
LATEST REVIEWS
IPO’s in focus (MEDS,RVMD,TFII)
Markets dove overnight on virus concerns out of China. Wall Street may suspect they'll stabilize and if I'm right, traders may be...
MAKE IT MODERN
PERFORMANCE TRAINING
Zogenix, Inc. (NASDAQ:ZGNX) Gets Positive Opinion From CHMP For FINTEPLA As A Therapy...
Zogenix, Inc. (NASDAQ:ZGNX) announced last month that it received a Committee for Medicinal Products for Human Use (CHMP) recommending marketing approval for FINTEPLA as...
Curis Inc. (NASDAQ: CRIS) Expands Executive Leadership With Addition Of Three New Executives
Curis Inc. (NASDAQ: CRIS) has expanded its executive leadership with the addition of Felix Geissler as VP of Medical Affairs, Dora Ferrari as VP...
Curis Inc. (NASDAQ: CRIS) Doses First Subject in The Combination Therapy Study of CA-4948...
Curis Inc. (NASDAQ: CRIS) has announced the dosing of the first patient in the combination therapy part of the Phase 1/2 clinical trial evaluating...
Why the Pullback in Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) is Likely a Gift
Without doubt, one of the
strongest stories in the biotech space over recent months has been Arrowhead
Pharmaceuticals Inc (NASDAQ:ARWR). Shares have powered well...
Time to load up on SPDR Gold Trust (NYSE:GLD)
SPDR Gold Trust (NYSE:GLD) is one stock that everyone run's towards in the time of panic.
Gold acts...
MAKE IT MODERN
